Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: A meta-analysis

被引:64
|
作者
Yao, Yao [1 ,2 ]
Ma, Cai-hong [3 ]
Tang, Hui-lin [1 ]
Hu, Yong-fang [1 ]
机构
[1] Peking Univ, Hosp 3, Therapeut Drug Monitoring & Clin Toxicol Ctr, Beijing 100191, Peoples R China
[2] Peking Univ, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing 100191, Peoples R China
[3] Peking Univ, Hosp 3, Ctr Reprod Med, Beijing 100191, Peoples R China
关键词
IVF; FSHR; Single nucleotide polymorphism; Meta-analysis; GENE POLYMORPHISMS; HYPERSTIMULATION; IVF; PHARMACOGENETICS; INFERTILITY; GENOTYPE;
D O I
10.1016/j.ymgme.2011.04.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: A common follicle-stimulating hormone (FSH) receptor (or FSHR) polymorphism Ser680Asn (rs6166) was found to be associated with altered ovarian response in women undergoing in-vitro fertilization. To further investigate such an association, a meta-analysis was conducted. Methods: A PubMed literature search was conducted to identify all cohort studies investigating such a relationship. The following parameters-basal FSH levels, total FSH doses, oocytes retrieved, and pregnancy rates-were used to evaluate the ovarian function, its response to exogenous FSH and in-vitro fertilization and intracytoplasmic sperm injection outcome. Results: A total of 1421 cases were collected from eight studies. Of them, a significantly lower basal FSH level was observed in patients harboring Asn/Asn (NN) genotype than those carrying the Ser/Ser (SS) genotype both in Asian (WMD: -2.57 mIU/ml, 95% CI: -2.96 to -2.19, P<0.0001) and Caucasian retrospective groups (WMD: -1.86 mIU/ml, 95%CI: -2.07 to -1.66, P<0.0001) with no heterogeneity. Moreover, carriers of the SS tended to require greater FSH doses than NN (WMD: -268.82 IU, 95% CI: -561.28 to 23.63, P = 0.07). Other parameters, such as oocytes retrieved and pregnancy rate, were not significantly different between the groups. Conclusion: Carriers of the SS variant have slightly higher basal FSH levels, tending to require higher doses of exogenous FSH for stimulation. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:388 / 393
页数:6
相关论文
共 50 条
  • [31] COST MINIMIZATION ANALYSIS OF HIGH PURITY URINARY HUMAN FOLLICLE-STIMULATING HORMONE FOR THE CONTROLLED OVARIAN STIMULATION IN IN-VITRO FERTILIZATION IN CHINA
    Zhu, S.
    Xu, Y.
    Zhang, Y.
    Wang, Z.
    Chen, T.
    Lin, Y.
    Xuan, J.
    VALUE IN HEALTH, 2019, 22 : S188 - S188
  • [32] Follicle-Stimulating Hormone Receptor Gene Haplotypes and Male Infertility in Estonian Population and Meta-Analysis
    Lend, Ave Kris
    Belousova, Anastasia
    Haller-Kikkatalo, Kadri
    Punab, Margus
    Poolamets, Olev
    Peters, Maire
    Salumets, Andres
    SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE, 2010, 56 (01) : 84 - 90
  • [33] Two follicle-stimulating hormone receptor polymorphisms and polycystic ovary syndrome risk: a meta-analysis
    Chen, Dao-Jun
    Ding, Rui
    Cao, Ji-Yu
    Zhai, Jin-Xia
    Zhang, Jia-Xiang
    Ye, Dong-Qing
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 182 : 27 - 32
  • [34] High-dose ovarian stimulation in young patients with high basal follicle-stimulating hormone undergoing in-vitro fertilization.
    Hammadieh, N
    Afnan, M
    Papaioannou, S
    Lenton, W
    Ola, B
    Sharif, K
    FERTILITY AND STERILITY, 2001, 76 (03) : S233 - S233
  • [35] Expression of follicle-stimulating hormone receptor (FSHR) in goat ovarian follicles and the impact of sequential culture medium on in vitro development of caprine preantral follicles
    Saraiva, M. V. A.
    Celestino, J. J. H.
    Araujo, V. R.
    Chaves, R. N.
    Almeida, A. P.
    Lima-Verde, I. B.
    Duarte, A. B. G.
    Silva, G. M.
    Martins, F. S.
    Bruno, J. B.
    Matos, M. H. T.
    Campello, C. C.
    Silva, J. R. V.
    Figueiredo, J. R.
    ZYGOTE, 2011, 19 (03) : 205 - 214
  • [36] In-Vitro Fertilization Outcome Predictors in Women With High Baseline Follicle-Stimulating Hormone Levels: Analysis of Over 1000 Cycles From A Tertiary Center
    Sahin, Gulnaz
    Akdogan, Aysin
    Aydin, Murat Hakan
    Tekindal, Mustafa Agah
    Goker, Ege Nazan Tavmergen
    Tavmergen, Erol
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2021, 25 (02): : 235 - 241
  • [37] Ovarian response and in vitro fertilization outcome in patients with reduced ovarian reserve who were stimulated with recombinant follicle-stimulating hormone or human menopausal gonadotropin
    Meo, F
    Ranieri, DM
    Khadum, I
    Serhal, P
    FERTILITY AND STERILITY, 2002, 77 (03) : 630 - 632
  • [38] Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis
    Sterrenburg, M. D.
    Veltman-Verhulst, S. M.
    Eijkemans, M. J. C.
    Hughes, E. G.
    Macklon, N. S.
    Broekmans, F. J.
    Fauser, B. C. J. M.
    HUMAN REPRODUCTION UPDATE, 2011, 17 (02) : 184 - 196
  • [39] Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization
    Balasch, J
    Fabregues, G
    Creus, M
    Moreno, V
    Puerto, B
    Penarrubia, J
    Carmona, F
    Vanrell, JA
    HUMAN REPRODUCTION, 1996, 11 (11) : 2400 - 2404
  • [40] Hormone-specific inhibitory influence of α-subunit Asn56 oligosaccharide on in vitro subunit association and follicle-stimulating hormone receptor binding of equine gonadotropins
    Butnev, VY
    Gotschall, RR
    Butnev, VY
    Baker, VL
    Moore, WT
    Bousfield, GR
    BIOLOGY OF REPRODUCTION, 1998, 58 (02) : 458 - 469